The UK's only GLP-1 programme built specifically for women's health, SheMed combines clinical oversight, real-world data, and personalised care shaped around metabolic science, hormone health, and the lived realities of women's lives.
Founded by Forbes 30 Under 30 winners in Science & Healthcare, SheMed has scaled to a community of over 100,000 women in under a year — making it one of the fastest-growing GLP-1 programmes in the UK. We're not just delivering treatment — we're generating the data the industry has been missing: how GLP-1s truly affect real women's lives in a non-clinical setting.
Safety at the core. Transparency that builds trust. Personalisation that defines every touchpoint.
Because women deserve healthcare designed around them.
SH